Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?

Bijan J. Borah, Naveen Pereira, Michael E. Farkouh

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
JournalCardiovascular Drugs and Therapy
Issue number1
StatePublished - Feb 1 2017

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this